# Ecuadorian Arriba Cacao (Theobroma cacao 'Arriba')

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ecuadorian-arriba-cacao
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Fruit
**Also Known As:** Arriba cacao, Ecuadorian fine flavor cacao, Ecuador Nacional cacao, Arriba Nacional, Theobroma cacao Nacional, Ecuador Arriba beans, Los Ríos cacao, Guayas cacao, Fine flavor Arriba

## Overview

Ecuadorian Arriba Cacao (Theobroma cacao 'Arriba') is a premium Nacional variety rich in flavan-3-ols, including epicatechin and procyanidins, which modulate endothelial nitric oxide synthase (eNOS) activity and suppress [pro-inflammatory cytokine](/ingredients/condition/inflammation) signaling. Its unusually high polyphenol density relative to common cacao cultivars drives research interest in [cardiovascular](/ingredients/condition/heart-health) and oncological applications.

## Health Benefits

• May support [endothelial function](/ingredients/condition/heart-health): In vitro studies show ethanolic extracts (25-100 ppm) reduced inflammatory markers IL-6 and sVCAM-1 in preeclamptic plasma models (PMID: 26955771) - Preliminary evidence
• Potential anticancer properties: Animal studies demonstrate synergistic effects with doxorubicin, showing organ protection and cancer cell inhibition at 200 mg/kg (PMIDs: 39594518, 35421091) - Preliminary evidence
• Anti-inflammatory activity: Preclinical studies show reduction in [pro-inflammatory cytokine](/ingredients/condition/inflammation)s (TNF-α, IL-1β, IL-6) through NF-κB signaling inhibition - Preliminary evidence
• [Antioxidant](/ingredients/condition/antioxidant) effects: Contains polyphenols including catechins and hirsutrin, with Ecuadorian genotypes showing elevated total polyphenol content in assays - Preliminary evidence
• May modulate cellular pathways: In vitro/in vivo studies show modulation of NF-κB, ERK, Akt/mTOR, and PDE4 pathways through flavonoids and alkaloids - Preliminary evidence

## Mechanism of Action

Epicatechin and procyanidins in Arriba Cacao activate endothelial nitric oxide synthase (eNOS) via PI3K/Akt phosphorylation, increasing nitric oxide bioavailability and reducing vascular inflammation. Ethanolic extracts at 25–100 ppm have been shown in vitro to suppress NF-κB-mediated transcription of IL-6 and soluble vascular cell adhesion molecule-1 (sVCAM-1), markers elevated in endothelial dysfunction. Theobromine and caffeine further contribute by inhibiting phosphodiesterase enzymes, elevating intracellular cAMP and reinforcing [anti-inflammatory](/ingredients/condition/inflammation) signaling cascades.

## Clinical Summary

In vitro research (PMID: 26955771) using preeclamptic plasma models demonstrated that Arriba Cacao ethanolic extracts at 25–100 ppm significantly reduced IL-6 and sVCAM-1 levels, suggesting a protective role in endothelial [inflammatory](/ingredients/condition/inflammation) conditions, though this remains preliminary cell-based evidence. Animal studies have documented synergistic cytotoxic effects when cacao polyphenol fractions are combined with doxorubicin, potentially reducing effective chemotherapy doses needed, though human translation is unconfirmed. No large-scale randomized controlled trials specific to the Arriba cultivar have been published; most human [cardiovascular](/ingredients/condition/heart-health) data is extrapolated from broader high-flavanol cacao research. The evidence base is currently preclinical and early-stage, warranting cautious interpretation before clinical recommendations can be made.

## Nutritional Profile

Ecuadorian Arriba (Nacional) cacao beans are notable for their exceptional flavanol content and aromatic profile. Per 100g of raw cacao powder derived from Arriba beans: Calories ~228 kcal, Total Fat ~13.7g (predominantly oleic acid ~34%, stearic acid ~33%, palmitic acid ~26%), Protein ~19.6g, Total Carbohydrates ~57.9g, Dietary Fiber ~33.2g (one of the highest fiber densities among fruit-derived foods), Net Carbs ~24.7g. Arriba Nacional is distinguished by unusually high floral-aromatic precursor compounds linked to its 'fine flavor' designation. Key micronutrients per 100g: Magnesium ~499mg (118% DV) — among the richest plant sources; Iron ~13.9mg (77% DV, non-heme, bioavailability enhanced by co-consumption with vitamin C); Zinc ~6.8mg (62% DV); Copper ~3.8mg (422% DV); Manganese ~3.8mg (165% DV); Phosphorus ~734mg (59% DV); Potassium ~1524mg (32% DV); Calcium ~128mg (10% DV). Bioactive compounds: Total flavanols estimated at 3,000–5,000mg/100g in raw unfermented beans, with Arriba Nacional reported to retain higher epicatechin and catechin concentrations than many Forastero varieties even after mild fermentation; Epicatechin: ~150–200mg/100g in processed powder; Catechin: ~50–100mg/100g; Procyanidins (B1, B2 dimers): ~400–600mg/100g; Theobromine: ~1,800–2,500mg/100g (primary methylxanthine, milder stimulant than caffeine); Caffeine: ~230–270mg/100g (approximately 10:1 theobromine-to-caffeine ratio); Phenylethylamine (PEA): ~0.4–0.66µg/g; Anandamide and anandamide precursors (N-acylethanolamines): trace amounts ~0.5–1.4µg/g; Tryptophan: ~293mg/100g ([serotonin](/ingredients/condition/mood) precursor). Arriba-specific aromatic compounds include high concentrations of floral linalool, geraniol, and benzaldehyde precursors formed during fermentation. Bioavailability notes: Flavanol bioavailability is significantly reduced by alkalizing (Dutch processing) — raw or minimally processed Arriba powder retains superior polyphenol activity. Phytate content (~1,800mg/100g) moderately inhibits iron and zinc absorption; pairing with organic acids improves mineral uptake. Stearic acid (saturated) is largely converted to oleic acid in vivo and considered neutral regarding [cardiovascular risk](/ingredients/condition/heart-health). Theobromine bioavailability is high (~98% oral absorption).

## Dosage & Preparation

No clinically studied human dosages exist for Ecuadorian Arriba Cacao. Preclinical studies used: ethanolic bean extracts (25-100 ppm in vitro), cocoa nibs powder (200 mg/kg in mice), and 200 mg/kg cocoa extract combined with chemotherapy in animal models. No human dosage ranges are available. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ecuadorian Arriba Cacao is generally well tolerated at culinary and moderate supplement doses, but its theobromine and caffeine content may cause tachycardia, [insomnia](/ingredients/condition/sleep), or gastrointestinal upset in sensitive individuals or at high doses. Due to its methylxanthine content, it may potentiate stimulant effects of caffeine-containing medications and may interact with monoamine oxidase inhibitors (MAOIs) by contributing to tyramine and phenylethylamine load. Polyphenol-rich cacao extracts may theoretically reduce iron absorption when consumed with iron supplements or iron-rich meals by chelating non-heme iron. Pregnant individuals should limit intake due to caffeine content, and those on anticoagulants such as warfarin should exercise caution given potential platelet-inhibiting effects of high-dose epicatechin.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses specific to Ecuadorian Arriba Cacao were identified. Evidence is limited to general T. cacao studies including one in vitro endothelial cell study (PMID: 26955771) and preclinical animal cancer models (PMIDs: 39594518, 35421091). All existing research consists of in vitro, in vivo animal, and cellular studies without human data.

## Historical & Cultural Context

Theobroma cacao, including Ecuadorian cultivars, has been used for thousands of years in Mesoamerican traditional medicine (Aztec/Maya systems) as a food, beverage, and remedy for fatigue, diarrhea, [inflammation](/ingredients/condition/inflammation), and fever. While no 'Arriba'-specific historical uses are documented, Ecuadorian regional genotypes share this medicinal legacy with variations in polyphenol and methylxanthine content influenced by local soils.

## Synergistic Combinations

Green tea extract, Quercetin, Resveratrol, Turmeric, Vitamin C

## Frequently Asked Questions

### What makes Arriba Cacao different from regular cacao supplements?

Arriba Cacao belongs to the rare Nacional variety of Theobroma cacao, which has been documented to contain a higher concentration of flavan-3-ols, particularly epicatechin and procyanidin B2, compared to common Forastero-derived cacao used in most supplements. This elevated polyphenol profile is linked to its distinct terroir in Ecuador's coastal lowlands and contributes to stronger in vitro anti-inflammatory activity at lower extract concentrations.

### Can Ecuadorian Arriba Cacao help with blood pressure?

Preclinical evidence suggests Arriba Cacao's epicatechin content activates eNOS via the PI3K/Akt pathway, increasing nitric oxide production which promotes vasodilation and may lower blood pressure. While general high-flavanol cacao studies show modest systolic blood pressure reductions of 2–4 mmHg in human trials, no RCTs have been conducted specifically on the Arriba cultivar, so direct blood pressure claims remain extrapolated from broader cacao research.

### Does Arriba Cacao have anticancer properties?

Animal studies have shown that polyphenol fractions from high-quality cacao, consistent with Arriba's profile, can act synergistically with doxorubicin to enhance cytotoxic effects against certain cancer cell lines, potentially allowing lower chemotherapy doses. However, these findings are from preclinical animal models, and no human clinical trials have confirmed anticancer efficacy for Arriba Cacao specifically, making this an area of emerging but unproven research.

### How much Arriba Cacao should I take daily for health benefits?

No standardized clinical dosage has been established specifically for Ecuadorian Arriba Cacao supplements. Research on general cacao flavanols suggests cardiovascular benefits in studies using 200–900 mg of cocoa flavanols per day; the European Food Safety Authority has associated 200 mg of cocoa flavanols with improved blood flow. Because Arriba is polyphenol-dense, lower gram quantities of raw powder may deliver equivalent flavanol doses, but standardization varies widely by product and processing method.

### Is Ecuadorian Arriba Cacao safe to take with heart medications?

Arriba Cacao contains theobromine, caffeine, and epicatechin, all of which can influence cardiovascular function and platelet aggregation, creating potential interactions with anticoagulants like warfarin, antiplatelet drugs like aspirin or clopidogrel, and antihypertensive medications. The vasodilatory effect of epicatechin via nitric oxide upregulation may additively lower blood pressure when combined with ACE inhibitors or calcium channel blockers. Patients on cardiac medications should consult a physician before using concentrated Arriba Cacao extracts, as whole dark chocolate consumed in normal dietary amounts poses a much lower interaction risk than standardized supplements.

### What is the evidence quality for Ecuadorian Arriba Cacao's effects on endothelial function?

Current evidence for Arriba Cacao's endothelial benefits comes primarily from in vitro studies using ethanolic extracts at concentrations of 25-100 ppm, which showed reductions in inflammatory markers IL-6 and sVCAM-1 in preeclamptic plasma models. This represents preliminary evidence that has not yet been validated in human clinical trials, meaning more research is needed before definitive health claims can be made. In vitro findings often do not translate directly to human supplementation, so caution is warranted when interpreting these results.

### Does Ecuadorian Arriba Cacao interact with chemotherapy drugs like doxorubicin?

Animal studies have demonstrated that Arriba Cacao may have synergistic effects when combined with doxorubicin, showing both organ protection and enhanced cancer cell inhibition at doses around 200 mg/kg in rodent models. However, these are preclinical findings and have not been tested in humans, so anyone undergoing chemotherapy should consult their oncologist before adding Arriba Cacao supplements. The potential for interaction exists based on animal data, but human safety and efficacy remain unstudied.

### Who should prioritize Ecuadorian Arriba Cacao supplementation based on current research?

Based on available evidence, individuals interested in cardiovascular health and endothelial function may be candidates for Arriba Cacao, though human studies are limited. Those with preeclampsy risk or inflammatory vascular conditions might benefit from consulting their healthcare provider about this cultivar, given the preliminary in vitro data on inflammatory markers. Currently, the evidence base is too preliminary to recommend Arriba Cacao over other evidence-supported cacao variants for any specific population.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*